Literature DB >> 17259864

Olfaction and neurodegeneration in HD.

Fernando A Barrios1, Leopoldo Gonzalez, Rafael Favila, Maria E Alonso, Perla M Salgado, Rosalinda Diaz, Juan Fernandez-Ruiz.   

Abstract

Olfactory deficits are present in many neurodegenerative diseases. It is not known, however, whether the olfactory deterioration is caused by a common neural deficit, or whether it is unique to each disease. We report here the effect of degeneration of different brain structures on olfactory impairment in Huntington's disease as determined by voxel-based morphometric analysis. The structures with the greatest effect on the olfactory deficit were the entorhinal cortex, the thalamus, the parahippocampal gyrus, and the caudate nucleus. Although various neuroimaging studies have shown previously that the caudate nucleus is involved in olfaction, this is the first demonstration that it is related to an olfactory dysfunction in a neurodegenerative disease. The results are discussed in relation to other neurodegenerative diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17259864     DOI: 10.1097/WNR.0b013e3280102302

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  19 in total

1.  Spinocerebellar ataxia type 2 neurodegeneration differentially affects error-based and strategic-based visuomotor learning.

Authors:  Israel Vaca-Palomares; Rosalinda Díaz; Roberto Rodríguez-Labrada; Jacqeline Medrano-Montero; Yaimé Vázquez-Mojena; Luis Velázquez-Pérez; Juan Fernandez-Ruiz
Journal:  Cerebellum       Date:  2013-12       Impact factor: 3.847

2.  Olfactory dysfunction in fragile X tremor ataxia syndrome.

Authors:  Jorge L Juncos; Joash T Lazarus; Julia Rohr; Emily G Allen; Lisa Shubeck; Debra Hamilton; Gloria Novak; Stephanie L Sherman
Journal:  Mov Disord       Date:  2012-09-24       Impact factor: 10.338

3.  The structural correlates of functional deficits in early huntington's disease.

Authors:  Christine Delmaire; Eve M Dumas; Michael A Sharman; Simon J A van den Bogaard; Romain Valabregue; Céline Jauffret; Damian Justo; Ralf Reilmann; Julie C Stout; David Craufurd; Sarah J Tabrizi; Raymund A C Roos; Alexandra Durr; Stéphane Lehéricy
Journal:  Hum Brain Mapp       Date:  2012-03-22       Impact factor: 5.038

4.  Altered learning, memory, and social behavior in type 1 taste receptor subunit 3 knock-out mice are associated with neuronal dysfunction.

Authors:  Bronwen Martin; Rui Wang; Wei-Na Cong; Caitlin M Daimon; Wells W Wu; Bin Ni; Kevin G Becker; Elin Lehrmann; William H Wood; Yongqing Zhang; Harmonie Etienne; Jaana van Gastel; Abdelkrim Azmi; Jonathan Janssens; Stuart Maudsley
Journal:  J Biol Chem       Date:  2017-05-18       Impact factor: 5.157

5.  Simple and Computer-assisted Olfactory Testing for Mice.

Authors:  Emanuele Brai; Lavinia Alberi
Journal:  J Vis Exp       Date:  2015-06-15       Impact factor: 1.355

Review 6.  Nanoparticles and the brain: cause for concern?.

Authors:  Günter Oberdörster; Alison Elder; Amber Rinderknecht
Journal:  J Nanosci Nanotechnol       Date:  2009-08

7.  Pitfalls in the use of voxel-based morphometry as a biomarker: examples from huntington disease.

Authors:  S M D Henley; G R Ridgway; R I Scahill; S Klöppel; S J Tabrizi; N C Fox; J Kassubek
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-24       Impact factor: 3.825

8.  Non-motor symptoms in Huntington's disease: a comparative study with Parkinson's disease.

Authors:  Tatiana Aldaz; Pasquale Nigro; Almudena Sánchez-Gómez; Celia Painous; Lluís Planellas; Pilar Santacruz; Ana Cámara; Yaroslau Compta; Francesc Valldeoriola; Maria J Martí; Esteban Muñoz
Journal:  J Neurol       Date:  2019-03-05       Impact factor: 4.849

9.  The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis.

Authors:  Mostafa Almasi; Mohammad Ali Sahraian; Fahimeh Haji Akhoundi; Hamid Reza Ezzati; Mohammad Rohani
Journal:  Basic Clin Neurosci       Date:  2021-01-01

Review 10.  Magnetic resonance imaging of Huntington's disease: preparing for clinical trials.

Authors:  S Klöppel; S M Henley; N Z Hobbs; R C Wolf; J Kassubek; S J Tabrizi; R S J Frackowiak
Journal:  Neuroscience       Date:  2009-01-29       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.